Chemokine panec-1 antibodies
AssigneeIncyte Pharmaceuticals, Inc.
InventorsRoger T. Coleman, Olga Bandman, Craig G. Wilde
Life of this patent
Estimating the term…
Loading patent…
AssigneeIncyte Pharmaceuticals, Inc.
InventorsRoger T. Coleman, Olga Bandman, Craig G. Wilde
Estimating the term…
The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.
An isolated antibody that specifically binds to a polypeptide
Dependencies are inferred from the claim text.